Showing results (61-70 of 116) with videos related to

Sort By:
Pageof 12
Plos One|November 22, 2023
Real world treatment sequences and outcomes for metastatic renal cell carcinomaGu-Shun Lai, Jian-Ri Li, Shian-Shiang Wang, et al.
BMC Urology|January 16, 2026
Treatment preferences of patients and physicians for early-stage and adjuvant treatment of urothelial carcinoma and renal cell carcinoma in Asia-Pacific: a discrete choice experimentEdmund Chiong, Lavinia Spain, Manish I Patel, et al.
Plos One|September 6, 2024
Impact of different visceral metastatic sites on survival in metastatic prostate cancer patientsGu-Shun Lai, Chuan-Shu Chen, Jason Chia-Hsien Cheng, et al.
Anticancer Research|October 3, 2022
Efficacy of Novel Hormone Agents in the Treatment of Metastatic Castration-resistant Prostate Cancer: A Real-world Retrospective StudyJian-Ri Li, Shian-Shiang Wang, Chuan-Shu Chen, et al.
Anticancer Research|June 23, 2023
Metastasectomy Improves Overall Survival in Metastatic Renal Cell Carcinoma: A Retrospective Cohort StudyJiun-Kai Chiou, Li-Wen Chang, Jian-Ri Li, et al.
Anticancer Research|December 30, 2022
Risk Analysis of Prostate Cancer Development Following Five-alpha Reductase Inhibitor Treatment for Benign Prostate HyperplasiaLi-Wen Chang, Shian-Shiang Wang, Cheng-Kuang Yang, et al.
Journal of Cellular and Molecular Medicine|March 23, 2024
MAOB expression correlates with a favourable prognosis in prostate cancer, and its genetic variants are associated with the metastasis of the diseaseHsiang-Ching Huang, Yi-Hsien Hsieh, Chi-Hao Hsiao, et al.
Anticancer Research|June 29, 2026
Real-world Comparison of Avelumab Maintenance and Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial CarcinomaTsung-Han Yen, Shian-Shiang Wang, Chaun-Shu Chen, et al.
Journal of the Chinese Medical Association : JCMA|December 27, 2011
PSA density as a better predictor of prostate cancer than percent-free PSA in a repeat biopsyChuan-Shu Chen, Shian-Shiang Wang, Jian-Ri Li, et al.
International Journal of Medical Sciences|November 2, 2019
Impact of GAS5 genetic polymorphism on prostate cancer susceptibility and clinicopathologic characteristicsChia-Yen Lin, Shian-Shiang Wang, Cheng-Kuang Yang, et al.
Pageof 12